AI-based prediction and prevention of drug adverse effects by real world data: focus on anticoagulation therapy

Acronym

AIPREDAE

Description of the granted funding

The research project “AI-based prediction and prevention of drug adverse effects by real world data: focus on anticoagulation (AI-PREDAE)” aims to identify risk factor profiles for major bleeding in anticoagulated patients using extensive real-world data and advanced feature selection techniques and to develop AI-based risk prediction model to support prevention of these adverse effects and safe prescribing in in clinical practice. By employing causal AI combined with a digital health twin approach and machine learning, our risk model has potential to surpass current clinical metrics, such as cumulative scores, which fail to account for cumulative effects of risk factors. This project promotes safer and optimized prescribing of anticoagulants. Our approach can also be applied to other classes of drugs.
Show more

Starting year

2026

End year

2030

Granted funding

Miia Tiihonen Orcid -palvelun logo
429 454 €


Funder

Research Council of Finland

Funding instrument

Academy projects

Decision maker

Scientific Council for Biosciences, Health and the Environment
10.06.2026

Other information

Funding decision number

377150

Fields of science

Pharmacy

Research fields

Farmasia